CWA Asset Management Group LLC trimmed its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) ...
In the preceding three months, 12 analysts have released ratings for Vertex (NASDAQ:VERX), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll find a ...
Vertex Pharmaceuticals (VRTX ... At the same time, the Dow lost 0.07%, and the tech-heavy Nasdaq lost 0.9%. Shares of the drugmaker witnessed a loss of 14.25% over the previous month, trailing ...
Fintel reports that on January 3, 2025, Raymond James downgraded their outlook for Vertex (LSE:0A3L) from Outperform to Market Perform. There are 474 funds or institutions reporting positions in ...
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Raymond James downgraded Vertex (VERX) to Market Perform from Outperform without a price target The firm repositioned several ratings throughout the application software sector at the start of 2025.
Nordea Investment Management AB increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.4% during the fourth quarter, Holdings Channel reports. The ...
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $402.49, representing a -1.13% change from its previous close.
Fintel reports that on December 31, 2024, DA Davidson initiated coverage of Vertex (LSE:0A3L) with a Buy recommendation. What is the Fund Sentiment? There are 474 funds or institutions reporting ...
Everence Capital Management Inc. trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5 ...
Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) shareholders might be concerned after seeing the share price ...
NASDAQ:VERX opened at $51.32 on Friday. The firm has a 50-day simple moving average of $51.64 and a two-hundred day simple moving average of $42.49. The firm has a market cap of $8.00 billion, a P ...